TY - JOUR AU - Mullard, A. PY - 2015 DA - 2015// TI - Use of personalized cancer drugs runs ahead of the science JO - Nature ID - Mullard2015 ER - TY - STD TI - More Canadians to benefit from personalized cancer treatment—Ontario Genomics [http://www.ontariogenomics.ca/news-events/news/more-canadians-to-benefit-from-personalized-cancer-treatment/]. Accessed 18 Oct 2016. UR - http://www.ontariogenomics.ca/news-events/news/more-canadians-to-benefit-from-personalized-cancer-treatment/ ID - ref2 ER - TY - STD TI - Fayerman P. Personalized cancer treatment on verge of revolutionizing care. Toronto: Postmedia Network Inc., Vancouver Sun; 2015. ID - ref3 ER - TY - STD TI - Mulholland A. Pill that sent cancer into remission may be a ‘one-off’, doc says. Toronto: Bell Media, CTV News; 2015. ID - ref4 ER - TY - BOOK AU - Stewart, B. AU - Wild, C. PY - 2014 DA - 2014// TI - World cancer report PB - International Agency for Research on Cancer CY - Lyon, France ID - Stewart2014 ER - TY - JOUR AU - Domchek, S. M. AU - Friebel, T. M. AU - Singer, C. F. AU - Evans, D. G. AU - Lynch, H. T. AU - Isaacs, C. PY - 2010 DA - 2010// TI - Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality JO - JAMA VL - 304 UR - https://doi.org/10.1001/jama.2010.1237 DO - 10.1001/jama.2010.1237 ID - Domchek2010 ER - TY - JOUR AU - Høberg-Vetti, H. AU - Bjorvatn, C. AU - Fiane, B. E. AU - Aas, T. AU - Woie, K. AU - Espelid, H. PY - 2015 DA - 2015// TI - BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study JO - Eur J Hum Genet VL - 24 UR - https://doi.org/10.1038/ejhg.2015.196 DO - 10.1038/ejhg.2015.196 ID - Høberg-Vetti2015 ER - TY - JOUR AU - Mavaddat, N. AU - Pharoah, P. D. P. AU - Michailidou, K. AU - Tyrer, J. AU - Brook, M. N. AU - Bolla, M. K. PY - 2015 DA - 2015// TI - Prediction of breast cancer risk based on profiling with common genetic variants JO - J Natl Cancer Inst VL - 107 UR - https://doi.org/10.1093/jnci/djv036 DO - 10.1093/jnci/djv036 ID - Mavaddat2015 ER - TY - JOUR AU - Easton, D. F. AU - Pharoah, P. D. P. AU - Antoniou, A. C. AU - Tischkowitz, M. AU - Tavtigian, S. V. AU - Nathanson, K. L. PY - 2015 DA - 2015// TI - Gene-panel sequencing and the prediction of breast-cancer risk JO - N Engl J Med VL - 372 UR - https://doi.org/10.1056/NEJMsr1501341 DO - 10.1056/NEJMsr1501341 ID - Easton2015 ER - TY - JOUR AU - Maas, P. AU - Barrdahl, M. AU - Joshi, A. D. AU - Auer, P. L. AU - Gaudet, M. M. AU - Milne, R. L. PY - 2016 DA - 2016// TI - Breast cancer risk from modifiable and nonmodifiable risk factors among white women in the United States JO - JAMA Oncol VL - 132 ID - Maas2016 ER - TY - STD TI - Garcia-Closas M, Gunsoy NB, Chatterjee N. Combined associations of genetic and environmental risk factors: implications for prevention of breast cancer. J Natl Cancer Inst. 2014;106:dju305–5 ID - ref11 ER - TY - JOUR AU - Foulkes, W. D. AU - Knoppers, B. M. AU - Turnbull, C. PY - 2016 DA - 2016// TI - Population genetic testing for cancer susceptibility: founder mutations to genomes JO - Nat Rev Clin Oncol VL - 13 UR - https://doi.org/10.1038/nrclinonc.2015.173 DO - 10.1038/nrclinonc.2015.173 ID - Foulkes2016 ER - TY - STD TI - The cost of sequencing a human genome [https://www.genome.gov/27565109/the-cost-of-sequencing-a-human-genome/]. Accessed 18 Oct 2016. UR - https://www.genome.gov/27565109/the-cost-of-sequencing-a-human-genome/ ID - ref13 ER - TY - JOUR AU - Strotman, L. N. AU - Millner, L. M. AU - Valdes, R. AU - Linder, M. W. PY - 2016 DA - 2016// TI - Liquid biopsies in oncology and the current regulatory landscape JO - Mol Diagn Ther VL - 20 UR - https://doi.org/10.1007/s40291-016-0220-5 DO - 10.1007/s40291-016-0220-5 ID - Strotman2016 ER - TY - JOUR AU - Cheng, F. AU - Su, L. AU - Qian, C. AU - Cheng, F. AU - Su, L. AU - Qian, C. PY - 2016 DA - 2016// TI - Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer JO - Oncotarget ID - Cheng2016 ER - TY - JOUR AU - Esposito, A. AU - Criscitiello, C. AU - Locatelli, M. AU - Milano, M. AU - Curigliano, G. PY - 2016 DA - 2016// TI - Liquid biopsies for solid tumors: understanding tumor heterogeneity and real time monitoring of early resistance to targeted therapies JO - Pharmacol Ther VL - 157 UR - https://doi.org/10.1016/j.pharmthera.2015.11.007 DO - 10.1016/j.pharmthera.2015.11.007 ID - Esposito2016 ER - TY - BOOK PY - 2016 DA - 2016// TI - Illumina forms new company to enable early cancer detection via blood-based screening PB - Business Wire CY - San Francisco/New York ID - ref17 ER - TY - JOUR AU - Sahm, F. AU - Schrimpf, D. AU - Jones, D. T. W. AU - Meyer, J. AU - Kratz, A. AU - Reuss, D. PY - 2016 DA - 2016// TI - Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets JO - Acta Neuropathol VL - 131 UR - https://doi.org/10.1007/s00401-015-1519-8 DO - 10.1007/s00401-015-1519-8 ID - Sahm2016 ER - TY - JOUR AU - Ross, J. S. AU - Wang, K. AU - Gay, L. AU - Otto, G. A. AU - White, E. AU - Iwanik, K. PY - 2015 DA - 2015// TI - Comprehensive genomic profiling of carcinoma of unknown primary site: new routes to targeted therapies JO - JAMA Oncol VL - 1 UR - https://doi.org/10.1001/jamaoncol.2014.216 DO - 10.1001/jamaoncol.2014.216 ID - Ross2015 ER - TY - JOUR AU - Louis, D. N. AU - Perry, A. AU - Reifenberger, G. AU - Deimling, A. AU - Figarella-Branger, D. AU - Cavenee, W. K. PY - 2016 DA - 2016// TI - The 2016 World Health Organization classification of tumors of the central nervous system: a summary JO - Acta Neuropathol VL - 131 UR - https://doi.org/10.1007/s00401-016-1545-1 DO - 10.1007/s00401-016-1545-1 ID - Louis2016 ER - TY - JOUR AU - Schwaederle, M. AU - Zhao, M. AU - Lee, J. J. AU - Eggermont, A. M. AU - Schilsky, R. L. AU - Mendelsohn, J. PY - 2015 DA - 2015// TI - Impact of precision medicine in diverse cancers: a meta-analysis of phase II clinical trials JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2015.61.5997 DO - 10.1200/JCO.2015.61.5997 ID - Schwaederle2015 ER - TY - JOUR AU - Willis, J. C. D. AU - Lord, G. M. PY - 2015 DA - 2015// TI - Immune biomarkers: the promises and pitfalls of personalized medicine JO - Nat Rev Immunol VL - 15 UR - https://doi.org/10.1038/nri3820 DO - 10.1038/nri3820 ID - Willis2015 ER - TY - JOUR AU - Rosenberg, S. A. PY - 2014 DA - 2014// TI - Decade in review—cancer immunotherapy: entering the mainstream of cancer treatment JO - Nat Rev Clin Oncol VL - 11 UR - https://doi.org/10.1038/nrclinonc.2014.174 DO - 10.1038/nrclinonc.2014.174 ID - Rosenberg2014 ER - TY - JOUR AU - Melero, I. AU - Gaudernack, G. AU - Gerritsen, W. AU - Huber, C. AU - Parmiani, G. AU - Scholl, S. PY - 2014 DA - 2014// TI - Therapeutic vaccines for cancer: an overview of clinical trials JO - Nat Rev Clin Oncol VL - 11 UR - https://doi.org/10.1038/nrclinonc.2014.111 DO - 10.1038/nrclinonc.2014.111 ID - Melero2014 ER - TY - JOUR AU - Vanneman, M. AU - Dranoff, G. PY - 2012 DA - 2012// TI - Combining immunotherapy and targeted therapies in cancer treatment JO - Nat Rev Cancer VL - 12 UR - https://doi.org/10.1038/nrc3237 DO - 10.1038/nrc3237 ID - Vanneman2012 ER - TY - JOUR AU - Wargo, J. A. AU - Cooper, Z. A. AU - Flaherty, K. T. PY - 2014 DA - 2014// TI - Universes collide: combining immunotherapy with targeted therapy for cancer JO - Cancer Discov VL - 4 UR - https://doi.org/10.1158/2159-8290.CD-14-0477 DO - 10.1158/2159-8290.CD-14-0477 ID - Wargo2014 ER - TY - JOUR AU - Hu-Lieskovan, S. AU - Robert, L. AU - Homet Moreno, B. AU - Ribas, A. PY - 2014 DA - 2014// TI - Combining targeted therapy with immunotherapy in BRAF-mutant melanoma: promise and challenges JO - J Clin Oncol VL - 32 UR - https://doi.org/10.1200/JCO.2013.52.1377 DO - 10.1200/JCO.2013.52.1377 ID - Hu-Lieskovan2014 ER - TY - JOUR AU - Sharma, P. AU - Allison, J. P. PY - 2015 DA - 2015// TI - The future of immune checkpoint therapy JO - Science VL - 3 UR - https://doi.org/10.1126/science.aaa8172 DO - 10.1126/science.aaa8172 ID - Sharma2015 ER - TY - STD TI - Cancer Pharmacogenomics [https://www.pharmgkb.org/page/cancerPgx]. Accessed 18 Oct 2016. UR - https://www.pharmgkb.org/page/cancerPgx ID - ref29 ER - TY - JOUR AU - Huang, M. AU - Shen, A. AU - Ding, J. AU - Geng, M. PY - 2014 DA - 2014// TI - Molecularly targeted cancer therapy: some lessons from the past decade JO - Trends Pharmacol Sci VL - 35 UR - https://doi.org/10.1016/j.tips.2013.11.004 DO - 10.1016/j.tips.2013.11.004 ID - Huang2014 ER - TY - JOUR AU - Bennett, N. C. AU - Farah, C. S. PY - 2014 DA - 2014// TI - Next-generation sequencing in clinical oncology: next steps towards clinical validation JO - Cancers VL - 6 UR - https://doi.org/10.3390/cancers6042296 DO - 10.3390/cancers6042296 ID - Bennett2014 ER - TY - JOUR AU - Tourneau, C. AU - Delord, J. -. P. AU - Gonçalves, A. AU - Gavoille, C. AU - Dubot, C. AU - Isambert, N. PY - 2015 DA - 2015// TI - Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial JO - Lancet Oncol VL - 16 UR - https://doi.org/10.1016/S1470-2045(15)00188-6 DO - 10.1016/S1470-2045(15)00188-6 ID - Tourneau2015 ER - TY - JOUR AU - Laskin, J. AU - Jones, S. AU - Aparicio, S. AU - Chia, S. AU - Ch’ng, C. AU - Deyell, R. PY - 2015 DA - 2015// TI - Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancers JO - Mol Case Stud VL - 1 UR - https://doi.org/10.1101/mcs.a000570 DO - 10.1101/mcs.a000570 ID - Laskin2015 ER - TY - JOUR AU - Syn, N. L. -. X. AU - Yong, W. -. P. AU - Goh, B. -. C. AU - Lee, S. -. C. PY - 2016 DA - 2016// TI - Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review JO - Expert Opin Drug Metab Toxicol VL - 12 UR - https://doi.org/10.1080/17425255.2016.1196187 DO - 10.1080/17425255.2016.1196187 ID - Syn2016 ER - TY - JOUR AU - Rehm, H. L. AU - Bale, S. J. AU - Bayrak-Toydemir, P. AU - Berg, J. S. AU - Brown, K. K. AU - Deignan, J. L. PY - 2013 DA - 2013// TI - ACMG clinical laboratory standards for next-generation sequencing JO - Genet Med VL - 15 UR - https://doi.org/10.1038/gim.2013.92 DO - 10.1038/gim.2013.92 ID - Rehm2013 ER - TY - JOUR AU - Sénécal, K. AU - Rahimzadeh, V. AU - Knoppers, B. M. AU - Fernandez, C. V. AU - Avard, D. AU - Sinnett, D. PY - 2015 DA - 2015// TI - Statement of principles on the return of research results and incidental findings in paediatric research: a multi-site consultative process JO - Genome VL - 58 UR - https://doi.org/10.1139/gen-2015-0092 DO - 10.1139/gen-2015-0092 ID - Sénécal2015 ER - TY - JOUR PY - 2014 DA - 2014// TI - Board of Directors: ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing JO - Genet Med VL - 17 ID - ref37 ER - TY - JOUR AU - Gargis, A. S. AU - Kalman, L. AU - Bick, D. P. AU - Silva, C. AU - Dimmock, D. P. AU - Funke, B. H. PY - 2015 DA - 2015// TI - Good laboratory practice for clinical next-generation sequencing informatics pipelines JO - Nat Biotechnol VL - 33 UR - https://doi.org/10.1038/nbt.3237 DO - 10.1038/nbt.3237 ID - Gargis2015 ER - TY - JOUR AU - Matthijs, G. AU - Souche, E. AU - Alders, M. AU - Corveleyn, A. AU - Eck, S. AU - Feenstra, I. PY - 2016 DA - 2016// TI - Guidelines for diagnostic next-generation sequencing JO - Eur J Hum Genet VL - 24 UR - https://doi.org/10.1038/ejhg.2015.226 DO - 10.1038/ejhg.2015.226 ID - Matthijs2016 ER - TY - JOUR AU - Nicol, D. AU - Bubela, T. AU - Chalmers, D. AU - Charbonneau, J. AU - Critchley, C. AU - Dickinson, J. PY - 2016 DA - 2016// TI - Precision medicine: drowning in a regulatory soup? JO - J Law Biosci VL - 3 UR - https://doi.org/10.1093/jlb/lsw018 DO - 10.1093/jlb/lsw018 ID - Nicol2016 ER - TY - STD TI - Implementing Genomics in Practice (IGNITE) [https://www.genome.gov/27554264/implementing-genomics-in-practice-ignite/]. Accessed 18 Oct 2016. UR - https://www.genome.gov/27554264/implementing-genomics-in-practice-ignite/ ID - ref41 ER - TY - BOOK PY - 2016 DA - 2016// TI - Applying an implementation science approach to genomic medicine: workshop summary. National Academies of Sciences, Engineering, and Medicine PB - National Academies Press (US) CY - Washington (DC) ID - ref42 ER - TY - JOUR AU - Cabana, M. D. AU - Rand, C. S. AU - Powe, N. R. AU - Wu, A. W. AU - Wilson, M. H. AU - Abboud, P. A. PY - 1999 DA - 1999// TI - Why don’t physicians follow clinical practice guidelines? JO - JAMA VL - 282 UR - https://doi.org/10.1001/jama.282.15.1458 DO - 10.1001/jama.282.15.1458 ID - Cabana1999 ER - TY - BOOK PY - 2003 DA - 2003// TI - Improving patient care—the implementation of change in health care PB - Wiley-Blackwell (US) CY - New Jersey ID - ref44 ER - TY - JOUR AU - Gagliardi, A. R. AU - Alhabib, S. AU - Shekelle, P. AU - Woolf, S. AU - Grimshaw, J. AU - Schunemann, H. PY - 2015 DA - 2015// TI - Trends in guideline implementation: a scoping systematic review JO - Implement Sci VL - 10 UR - https://doi.org/10.1186/s13012-015-0247-8 DO - 10.1186/s13012-015-0247-8 ID - Gagliardi2015 ER - TY - JOUR AU - Meyerson, M. AU - Gabriel, S. AU - Getz, G. PY - 2010 DA - 2010// TI - Advances in understanding cancer genomes through second-generation sequencing JO - Nat Rev Genet VL - 11 UR - https://doi.org/10.1038/nrg2841 DO - 10.1038/nrg2841 ID - Meyerson2010 ER - TY - JOUR AU - Allen, E. M. AU - Wagle, N. AU - Stojanov, P. AU - Perrin, D. L. AU - Cibulskis, K. AU - Marlow, S. PY - 2014 DA - 2014// TI - Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine JO - Nat Med VL - 20 UR - https://doi.org/10.1038/nm.3559 DO - 10.1038/nm.3559 ID - Allen2014 ER - TY - JOUR AU - Ding, L. AU - Wendl, M. C. AU - McMichael, J. F. AU - Raphael, B. J. PY - 2014 DA - 2014// TI - Expanding the computational toolbox for mining cancer genomes JO - Nat Rev Genet VL - 15 UR - https://doi.org/10.1038/nrg3767 DO - 10.1038/nrg3767 ID - Ding2014 ER - TY - JOUR AU - Krøigård, A. B. AU - Thomassen, M. AU - Lænkholm, A. -. V. AU - Kruse, T. A. AU - Larsen, M. J. PY - 2016 DA - 2016// TI - Evaluation of nine somatic variant callers for detection of somatic mutations in exome and targeted deep sequencing data JO - PLoS One VL - 11 UR - https://doi.org/10.1371/journal.pone.0151664 DO - 10.1371/journal.pone.0151664 ID - Krøigård2016 ER - TY - JOUR AU - Wang, Q. AU - Jia, P. AU - Li, F. AU - Chen, H. AU - Ji, H. AU - Hucks, D. PY - 2013 DA - 2013// TI - Detecting somatic point mutations in cancer genome sequencing data: a comparison of mutation callers JO - Genome Med VL - 5 UR - https://doi.org/10.1186/gm495 DO - 10.1186/gm495 ID - Wang2013 ER - TY - JOUR AU - Alioto, T. S. AU - Buchhalter, I. AU - Derdak, S. AU - Hutter, B. AU - Eldridge, M. D. AU - Hovig, E. PY - 2015 DA - 2015// TI - A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing JO - Nat Commun VL - 6 UR - https://doi.org/10.1038/ncomms10001 DO - 10.1038/ncomms10001 ID - Alioto2015 ER - TY - JOUR AU - McDermott, U. PY - 2015 DA - 2015// TI - Next-generation sequencing and empowering personalised cancer medicine JO - Drug Discov Today VL - 20 UR - https://doi.org/10.1016/j.drudis.2015.10.008 DO - 10.1016/j.drudis.2015.10.008 ID - McDermott2015 ER - TY - JOUR AU - Brownstein, C. A. AU - Beggs, A. H. AU - Homer, N. AU - Merriman, B. AU - Yu, T. W. AU - Flannery, K. C. PY - 2014 DA - 2014// TI - An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge JO - Genome Biol VL - 15 UR - https://doi.org/10.1186/gb-2014-15-3-r53 DO - 10.1186/gb-2014-15-3-r53 ID - Brownstein2014 ER - TY - JOUR AU - Amendola, L. M. AU - Jarvik, G. P. AU - Leo, M. AU - McLaughlin, H. M. AU - Akkari, H. AU - Amaral, M. PY - 2016 DA - 2016// TI - Performance of ACMG/AMP variant interpretation guidelines among nine laboratories in the Clinical Sequencing Exploratory Research (CSER) consortium JO - Am J Hum Genet VL - 98 UR - https://doi.org/10.1016/j.ajhg.2016.03.024 DO - 10.1016/j.ajhg.2016.03.024 ID - Amendola2016 ER - TY - STD TI - IGSR. The International Genome Sample Resource [http://www.1000genomes.org/data-portal/sample]. Accessed 18 Oct 2016. UR - http://www.1000genomes.org/data-portal/sample ID - ref55 ER - TY - STD TI - dbSNP – Short Genetic Variations [http://www.ncbi.nlm.nih.gov/SNP/]. Accessed 18 Oct 2016. UR - http://www.ncbi.nlm.nih.gov/SNP/ ID - ref56 ER - TY - STD TI - ExAC Browser – Exome Aggregation Consortium [http://exac.broadinstitute.org/]. Accessed 18 Oct 2016. UR - http://exac.broadinstitute.org/ ID - ref57 ER - TY - STD TI - Exome Variant Server [http://evs.gs.washington.edu/EVS/]. Accessed 18 Oct 2016. UR - http://evs.gs.washington.edu/EVS/ ID - ref58 ER - TY - JOUR AU - Gonzalez-Garay, M. L. AU - McGuire, A. L. AU - Pereira, S. AU - Caskey, C. T. PY - 2013 DA - 2013// TI - Personalized genomic disease risk of volunteers JO - Proc Natl Acad Sci U S A VL - 110 UR - https://doi.org/10.1073/pnas.1315934110 DO - 10.1073/pnas.1315934110 ID - Gonzalez-Garay2013 ER - TY - JOUR AU - Chen, R. AU - Shi, L. AU - Hakenberg, J. AU - Naughton, B. AU - Sklar, P. AU - Zhang, J. PY - 2016 DA - 2016// TI - Analysis of 589,306 genomes identifies individuals resilient to severe Mendelian childhood diseases JO - Nat Biotechnol VL - 34 UR - https://doi.org/10.1038/nbt.3514 DO - 10.1038/nbt.3514 ID - Chen2016 ER - TY - JOUR AU - Boycott, K. M. AU - Vanstone, M. R. AU - Bulman, D. E. AU - MacKenzie, A. E. PY - 2013 DA - 2013// TI - Rare-disease genetics in the era of next-generation sequencing: discovery to translation JO - Nat Rev Genet VL - 14 UR - https://doi.org/10.1038/nrg3555 DO - 10.1038/nrg3555 ID - Boycott2013 ER - TY - STD TI - COSMIC – Catalogue of somatic mutations in cancer [http://cancer.sanger.ac.uk/cosmic]. Accessed 18 Oct 2016. UR - http://cancer.sanger.ac.uk/cosmic ID - ref62 ER - TY - STD TI - cBioPortal for Cancer Genomics [http://www.cbioportal.org/]. Accessed 18 Oct 2016. UR - http://www.cbioportal.org/ ID - ref63 ER - TY - STD TI - TARGET: Therapeutically Applicable Research To Generate Effective Treatments [https://ocg.cancer.gov/programs/target]. Accessed 18 Oct 2016. UR - https://ocg.cancer.gov/programs/target ID - ref64 ER - TY - STD TI - Jude PeCan Data Portal [https://pecan.stjude.org/home]. Accessed 18 Oct 2016. UR - https://pecan.stjude.org/home ID - ref65 ER - TY - STD TI - My Cancer Genome [https://www.mycancergenome.org/]. Accessed 18 Oct 2016. UR - https://www.mycancergenome.org/ ID - ref66 ER - TY - JOUR AU - Jiang, Y. -. H. AU - Wang, Y. AU - Xiu, X. AU - Choy, K. W. AU - Pursley, A. N. AU - Cheung, S. W. PY - 2014 DA - 2014// TI - Genetic diagnosis of autism spectrum disorders: the opportunity and challenge in the genomics era JO - Crit Rev Clin Lab Sci VL - 51 UR - https://doi.org/10.3109/10408363.2014.910747 DO - 10.3109/10408363.2014.910747 ID - Jiang2014 ER - TY - STD TI - TCGA – The Cancer Genome Atlas [http://cancergenome.nih.gov/]. Accessed 18 Oct 2016. UR - http://cancergenome.nih.gov/ ID - ref68 ER - TY - STD TI - International Cancer Genome Consortium [http://icgc.org/]. Accessed 18 Oct 2016. UR - http://icgc.org/ ID - ref69 ER - TY - STD TI - The Case for the International Cancer Genome Consortium for Medicine. The International Cancer Genome Consortium for Medicine (ICGC-Med). 2016. [https://icgcmed.org/files/ICGCmed_White_Paper_April_2016.pdf]. Accessed 18 Oct 2016. UR - https://icgcmed.org/files/ICGCmed_White_Paper_April_2016.pdf ID - ref70 ER - TY - STD TI - Global Alliance for Genomics and Health [https://genomicsandhealth.org/]. Accessed 18 Oct 2016. UR - https://genomicsandhealth.org/ ID - ref71 ER - TY - STD TI - BRCA Exchange [http://brcaexchange.org/]. Accessed 18 Oct 2016. UR - http://brcaexchange.org/ ID - ref72 ER - TY - STD TI - Pollak A. Genetic test firm to make customers’ data publicly available. The New York Times. 2016. ID - ref73 ER - TY - STD TI - AmbryShare [https://share.ambrygen.com/]. Accessed 18 Oct 2016. UR - https://share.ambrygen.com/ ID - ref74 ER - TY - STD TI - Trickling Toward Precision Medicine. genomeweb 2016. ID - ref75 ER - TY - STD TI - PharmGKB – The Pharmacogenomics Knowledgebase [https://www.pharmgkb.org/]. Accessed 18 Oct 2016. UR - https://www.pharmgkb.org/ ID - ref76 ER - TY - STD TI - ClinicalTrials.gov [https://clinicaltrials.gov/]. Accessed 18 Oct 2016. UR - https://clinicaltrials.gov/ ID - ref77 ER - TY - JOUR AU - Mardis, E. R. PY - 2014 DA - 2014// TI - The translation of cancer genomics: time for a revolution in clinical cancer care JO - Genome Med VL - 6 UR - https://doi.org/10.1186/gm539 DO - 10.1186/gm539 ID - Mardis2014 ER - TY - STD TI - Ledford H. AstraZeneca launches project to sequence 2 million genomes. Nature. 2016;532:427–7. ID - ref79 ER - TY - JOUR AU - Simon, R. AU - Roychowdhury, S. PY - 2013 DA - 2013// TI - Implementing personalized cancer genomics in clinical trials JO - Nat Rev Drug Discov VL - 12 UR - https://doi.org/10.1038/nrd3979 DO - 10.1038/nrd3979 ID - Simon2013 ER - TY - JOUR AU - Goldfeder, R. L. AU - Priest, J. R. AU - Zook, J. M. AU - Grove, M. E. AU - Waggott, D. AU - Wheeler, M. T. PY - 2016 DA - 2016// TI - Medical implications of technical accuracy in genome sequencing JO - Genome Med VL - 8 UR - https://doi.org/10.1186/s13073-016-0269-0 DO - 10.1186/s13073-016-0269-0 ID - Goldfeder2016 ER - TY - JOUR AU - Linderman, M. D. AU - Brandt, T. AU - Edelmann, L. AU - Jabado, O. AU - Kasai, Y. AU - Kornreich, R. PY - 2014 DA - 2014// TI - Analytical validation of whole exome and whole genome sequencing for clinical applications JO - BMC Med Genomics VL - 7 UR - https://doi.org/10.1186/1755-8794-7-20 DO - 10.1186/1755-8794-7-20 ID - Linderman2014 ER - TY - JOUR AU - Hatz, M. H. M. AU - Schremser, K. AU - Rogowski, W. H. PY - 2014 DA - 2014// TI - Is individualized medicine more cost-effective? A systematic review JO - Pharmacoeconomics VL - 32 UR - https://doi.org/10.1007/s40273-014-0143-0 DO - 10.1007/s40273-014-0143-0 ID - Hatz2014 ER - TY - JOUR AU - Blay, J. -. Y. AU - Tredan, O. AU - Ray-Coquard, I. AU - Rivoire, M. AU - Mehlen, P. AU - Puisieux, A. PY - 2015 DA - 2015// TI - Fifteen important questions for oncology to be addressed from 2015 JO - Bull Cancer VL - 102 UR - https://doi.org/10.1016/S0007-4551(15)31214-5 DO - 10.1016/S0007-4551(15)31214-5 ID - Blay2015 ER - TY - JOUR AU - Joly, Y. AU - Knoppers, B. M. PY - 2014 DA - 2014// TI - Personalized medicine: equity and access JO - Med Sci VL - 2 ID - Joly2014 ER - TY - JOUR AU - Joyner, M. J. AU - Paneth, N. PY - 2015 DA - 2015// TI - Seven questions for personalized medicine JO - JAMA VL - 314 UR - https://doi.org/10.1001/jama.2015.7725 DO - 10.1001/jama.2015.7725 ID - Joyner2015 ER - TY - JOUR AU - Rogowski, W. AU - Payne, K. AU - Schnell-Inderst, P. AU - Manca, A. AU - Rochau, U. AU - Jahn, B. PY - 2015 DA - 2015// TI - Concepts of “personalization” in personalized medicine: implications for economic evaluation JO - Pharmacoeconomics VL - 33 UR - https://doi.org/10.1007/s40273-014-0211-5 DO - 10.1007/s40273-014-0211-5 ID - Rogowski2015 ER - TY - BOOK AU - Lu, D. Y. PY - 2014 DA - 2014// TI - Personalized cancer chemotherapy: an effective way of enhancing outcomes in clinics PB - Elsevier CY - Amsterdam ID - Lu2014 ER - TY - JOUR AU - Li, W. PY - 2015 DA - 2015// TI - The era of nanotechnology and omics sciences JO - Eur J Biomed Res VL - 1 UR - https://doi.org/10.18088/ejbmr.1.1.2015.pp1-2 DO - 10.18088/ejbmr.1.1.2015.pp1-2 ID - Li2015 ER - TY - CHAP AU - Sonis, S. T. PY - 2015 DA - 2015// TI - Genomics, personalized medicine, and supportive cancer care BT - Educational Book 2015 PB - American Society of Clinical Oncology University CY - Alexandria ID - Sonis2015 ER - TY - JOUR AU - Tursz, T. AU - Bernards, R. PY - 2015 DA - 2015// TI - Hurdles on the road to personalized medicine JO - Mol Oncol VL - 9 UR - https://doi.org/10.1016/j.molonc.2014.08.009 DO - 10.1016/j.molonc.2014.08.009 ID - Tursz2015 ER - TY - JOUR AU - Hanahan, D. AU - Weinberg, R. A. PY - 2011 DA - 2011// TI - Hallmarks of cancer: the next generation JO - Cell VL - 144 UR - https://doi.org/10.1016/j.cell.2011.02.013 DO - 10.1016/j.cell.2011.02.013 ID - Hanahan2011 ER - TY - STD TI - Lung Cancer Master Protocol (Lung-MAP) Clinical Trials [http://www.lung-map.org/]. Accessed 18 Oct 2016. UR - http://www.lung-map.org/ ID - ref93 ER - TY - STD TI - National Lung Matrix Trial. Multi-drug Phase II Trial in Non-Small Cell Lung Cancer [https://clinicaltrials.gov/show/NCT02664935]. Accessed 18 Oct 2016. UR - https://clinicaltrials.gov/show/NCT02664935 ID - ref94 ER - TY - STD TI - Proof-of-Concept Study To Stratify Targeted Therapies Adapted To Molecular Profiling (MAPPYACTS) [https://clinicaltrials.gov/ct2/show/study/NCT02613962?term=MAPPYACTS&rank=1]. Accessed 18 Oct 2016. UR - https://clinicaltrials.gov/ct2/show/study/NCT02613962?term=MAPPYACTS&rank=1 ID - ref95 ER - TY - STD TI - Integrated Molecular Profiling in Advanced Cancers Trial (IMPACT) [https://clinicaltrials.gov/ct2/show/NCT01505400?term=IMPACT&cond=%22Carcinoma%22&state1=NA%3ACA%3AON&rank=6]. Accessed 18 Oct 2016. UR - https://clinicaltrials.gov/ct2/show/NCT01505400?term=IMPACT&cond=%22Carcinoma%22&state1=NA%3ACA%3AON&rank=6 ID - ref96 ER - TY - STD TI - Individualized Molecular Profiling for Allocation to Clinical Trials Project (IMPACT) [https://clinicaltrials.gov/ct2/show/NCT02806388?term=IMPACT&rank=9]. Accessed 18 Oct 2016. UR - https://clinicaltrials.gov/ct2/show/NCT02806388?term=IMPACT&rank=9 ID - ref97 ER - TY - CHAP AU - Piros, E. AU - Petak, I. AU - Erdos, A. AU - Hautman, J. AU - Lisziewicz, J. ED - Bawa, R. ED - Audette, G. F. ED - Reese, B. PY - 2016 DA - 2016// TI - Market opportunity for molecular diagnostics in personalized cancer therapy BT - Handbook of clinical nanomedicine. Law, business, regulation, safety, and risk PB - Francis CY - Stanford ID - Piros2016 ER - TY - JOUR AU - Carrera, P. AU - IJzerman, M. J. PY - 2016 DA - 2016// TI - Are current ICER thresholds outdated? Valuing medicines in the era of personalized healthcare JO - Expert Rev Pharmacoecon Outcomes Res VL - 6 ID - Carrera2016 ER - TY - JOUR AU - Aronson, S. J. AU - Rehm, H. L. PY - 2015 DA - 2015// TI - Building the foundation for genomics in precision medicine JO - Nature VL - 526 UR - https://doi.org/10.1038/nature15816 DO - 10.1038/nature15816 ID - Aronson2015 ER - TY - JOUR AU - Vrijenhoek, T. AU - Kraaijeveld, K. AU - Elferink, M. AU - Ligt, J. AU - Kranendonk, E. AU - Santen, G. PY - 2015 DA - 2015// TI - Next-generation sequencing-based genome diagnostics across clinical genetics centers: implementation choices and their effects JO - Eur J Hum Genet VL - 23 UR - https://doi.org/10.1038/ejhg.2014.279 DO - 10.1038/ejhg.2014.279 ID - Vrijenhoek2015 ER - TY - JOUR AU - Julia, S. AU - Bertier, G. AU - Cambon-Thomsen, A. PY - 2016 DA - 2016// TI - Quand l’anticipation devient plurielle : la complexité des données génomiques à l’épreuve des pratiques professionnelles JO - Rev française d’éthique appliquée VL - 2 ID - Julia2016 ER - TY - JOUR AU - Devon, K. M. AU - Lerner-Ellis, J. P. AU - Ganai, S. AU - Angelos, P. PY - 2015 DA - 2015// TI - Ethics and genomic medicine, how to navigate decisions in surgical oncology JO - J Surg Oncol VL - 111 UR - https://doi.org/10.1002/jso.23771 DO - 10.1002/jso.23771 ID - Devon2015 ER - TY - JOUR AU - McGowan, M. L. AU - Settersten, R. A. AU - Juengst, E. T. AU - Fishman, J. R. PY - 2014 DA - 2014// TI - Integrating genomics into clinical oncology: ethical and social challenges from proponents of personalized medicine JO - Urol Oncol Semin Orig Investig VL - 32 UR - https://doi.org/10.1016/j.urolonc.2013.10.009 DO - 10.1016/j.urolonc.2013.10.009 ID - McGowan2014 ER - TY - JOUR AU - Fiore, R. N. AU - Goodman, K. W. PY - 2016 DA - 2016// TI - Precision medicine ethics JO - Curr Opin Oncol VL - 28 UR - https://doi.org/10.1097/CCO.0000000000000247 DO - 10.1097/CCO.0000000000000247 ID - Fiore2016 ER - TY - STD TI - Public Population Project in Genomics and Society [http://www.p3g.org/]. Accessed 18 Oct 2016. UR - http://www.p3g.org/ ID - ref106 ER - TY - JOUR AU - Guston, D. H. PY - 2014 DA - 2014// TI - Understanding “anticipatory governance.” JO - Soc Stud Sci VL - 44 UR - https://doi.org/10.1177/0306312713508669 DO - 10.1177/0306312713508669 ID - Guston2014 ER - TY - STD TI - International Congress on Personalized Healthcare [http://www.icphc.org/]. Accessed 18 Oct 2016. UR - http://www.icphc.org/ ID - ref108 ER - TY - JOUR AU - Austin, J. PY - 2015 DA - 2015// TI - The effect of genetic test-based risk information on behavioral outcomes. A critical examination of failed trials and a call to action JO - Am J Med Genet Part A VL - 167 UR - https://doi.org/10.1002/ajmg.a.37289 DO - 10.1002/ajmg.a.37289 ID - Austin2015 ER - TY - JOUR AU - Hollands, G. J. AU - French, D. P. AU - Griffin, S. J. AU - Prevost, A. T. AU - Sutton, S. AU - King, S. PY - 2016 DA - 2016// TI - The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis JO - BMJ VL - 352 UR - https://doi.org/10.1136/bmj.i1102 DO - 10.1136/bmj.i1102 ID - Hollands2016 ER - TY - CHAP AU - Marteau, T. M. AU - French, D. P. AU - Griffin, S. J. AU - Prevost, A. T. AU - Sutton, S. AU - Watkinson, C. ED - Marteau, T. M. PY - 2010 DA - 2010// TI - Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours BT - Cochrane Database of Systematic Reviews PB - Sons CY - Chichester, UK ID - Marteau2010 ER - TY - JOUR AU - Persky, S. AU - Ferrer, R. A. AU - Klein, W. M. P. PY - 2016 DA - 2016// TI - Genomic information may inhibit weight-related behavior change inclinations among individuals in a fear state JO - Ann Behav Med VL - 50 UR - https://doi.org/10.1007/s12160-016-9771-2 DO - 10.1007/s12160-016-9771-2 ID - Persky2016 ER - TY - JOUR AU - Kammin, T. AU - Fenton, A. K. AU - Thirlaway, K. PY - 2015 DA - 2015// TI - A genetic lung cancer susceptibility test may have a positive effect on smoking cessation JO - J Genet Couns VL - 24 UR - https://doi.org/10.1007/s10897-014-9766-8 DO - 10.1007/s10897-014-9766-8 ID - Kammin2015 ER - TY - JOUR AU - Jatoi, A. AU - Foster, N. R. AU - Kalli, K. R. AU - Vierkant, R. A. AU - Zhang, Z. AU - Larson, M. C. PY - 2015 DA - 2015// TI - Prior oral contraceptive use in ovarian cancer patients: assessing associations with overall and progression-free survival JO - BMC Cancer VL - 15 UR - https://doi.org/10.1186/s12885-015-1774-z DO - 10.1186/s12885-015-1774-z ID - Jatoi2015 ER - TY - JOUR AU - Rieder, V. AU - Salama, M. AU - Glöckner, L. AU - Muhr, D. AU - Berger, A. AU - Tea, M. -. K. PY - 2016 DA - 2016// TI - Effect of lifestyle and reproductive factors on the onset of breast cancer in female BRCA 1 and 2 mutation carriers JO - Mol Genet Genomic Med VL - 4 UR - https://doi.org/10.1002/mgg3.191 DO - 10.1002/mgg3.191 ID - Rieder2016 ER - TY - JOUR AU - Vohra, J. AU - Marmot, M. G. AU - Bauld, L. AU - Hiatt, R. A. PY - 2016 DA - 2016// TI - Socioeconomic position in childhood and cancer in adulthood: a rapid-review JO - J Epidemiol Community Health VL - 70 UR - https://doi.org/10.1136/jech-2015-206274 DO - 10.1136/jech-2015-206274 ID - Vohra2016 ER - TY - JOUR AU - Byers, T. AU - Wender, R. C. AU - Jemal, A. AU - Baskies, A. M. AU - Ward, E. E. AU - Brawley, O. W. PY - 2016 DA - 2016// TI - The American Cancer Society challenge goal to reduce US cancer mortality by 50 % between 1990 and 2015: results and reflections JO - CA Cancer J Clin VL - 66 UR - https://doi.org/10.3322/caac.21348 DO - 10.3322/caac.21348 ID - Byers2016 ER - TY - JOUR AU - Friebel, T. M. AU - Domchek, S. M. AU - Rebbeck, T. R. PY - 2014 DA - 2014// JO - J Natl Cancer Inst VL - 106 UR - https://doi.org/10.1093/jnci/dju091 DO - 10.1093/jnci/dju091 ID - Friebel2014 ER - TY - JOUR AU - Caulfield, T. AU - Chandrasekharan, S. AU - Joly, Y. AU - Cook-Deegan, R. PY - 2013 DA - 2013// TI - Harm, hype and evidence: ELSI research and policy guidance JO - Genome Med VL - 5 UR - https://doi.org/10.1186/gm425 DO - 10.1186/gm425 ID - Caulfield2013 ER - TY - STD TI - National Cancer Intelligence Network. Cancer by deprivation in England - incidence, 1996–2010, mortality, 1997–2011. Public Health England and Cancer Research UK. 2014. [http://www.ncin.org.uk/about_ncin/cancer_by_deprivation_in_england]. Accessed 18 Oct 2016. UR - http://www.ncin.org.uk/about_ncin/cancer_by_deprivation_in_england ID - ref120 ER - TY - JOUR AU - Halverson, C. M. AU - Clift, K. E. AU - McCormick, J. B. PY - 2016 DA - 2016// TI - Was it worth it? Patients’ perspectives on the perceived value of genomic-based individualized medicine JO - J Community Genet VL - 7 UR - https://doi.org/10.1007/s12687-016-0260-x DO - 10.1007/s12687-016-0260-x ID - Halverson2016 ER - TY - JOUR AU - Lupo, P. J. AU - Robinson, J. AU - Diamond, P. AU - Jamal, L. AU - Danysh, H. PY - 2016 DA - 2016// TI - Patients’ perceived utility of whole-genome sequencing for their healthcare: findings from the MedSeq project JO - Per Med VL - 13 UR - https://doi.org/10.2217/pme.15.45 DO - 10.2217/pme.15.45 ID - Lupo2016 ER - TY - JOUR AU - McCullough, L. B. AU - Slashinski, M. J. AU - McGuire, A. L. AU - Street, R. L. AU - Eng, C. M. AU - Gibbs, R. A. PY - 2016 DA - 2016// TI - Is whole-exome sequencing an ethically disruptive technology? Perspectives of pediatric oncologists and parents of pediatric patients with solid tumors JO - Pediatr Blood Cancer VL - 63 UR - https://doi.org/10.1002/pbc.25815 DO - 10.1002/pbc.25815 ID - McCullough2016 ER - TY - JOUR AU - Pavelić, K. AU - Martinovi, T. AU - Kraljevi, S. PY - 2015 DA - 2015// TI - Do we understand the personalized medicine paradigm JO - EMBO Rep VL - 16 UR - https://doi.org/10.15252/embr.201439609 DO - 10.15252/embr.201439609 ID - Pavelić2015 ER - TY - JOUR AU - McCarthy, J. J. AU - McLeod, H. L. AU - Ginsburg, G. S. PY - 2013 DA - 2013// TI - Genomic medicine: a decade of successes, challenges, and opportunities JO - Sci Transl Med VL - 5 UR - https://doi.org/10.1126/scitranslmed.3005785 DO - 10.1126/scitranslmed.3005785 ID - McCarthy2013 ER - TY - JOUR AU - Manolio, T. A. AU - Abramowicz, M. AU - Al-Mulla, F. AU - Anderson, W. AU - Balling, R. AU - Berger, A. C. PY - 2015 DA - 2015// TI - Global implementation of genomic medicine: we are not alone JO - Sci Transl Med VL - 7 UR - https://doi.org/10.1126/scitranslmed.aab0194 DO - 10.1126/scitranslmed.aab0194 ID - Manolio2015 ER - TY - JOUR AU - Arnedos, M. AU - Vielh, P. AU - Soria, J. -. C. AU - Andre, F. PY - 2014 DA - 2014// TI - The genetic complexity of common cancers and the promise of personalized medicine: is there any hope? JO - J Pathol VL - 232 UR - https://doi.org/10.1002/path.4276 DO - 10.1002/path.4276 ID - Arnedos2014 ER - TY - JOUR AU - Dienstmann, R. AU - Rodon, J. AU - Barretina, J. AU - Tabernero, J. PY - 2013 DA - 2013// TI - Genomic medicine frontier in human solid tumors: prospects and challenges JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.45.2268 DO - 10.1200/JCO.2012.45.2268 ID - Dienstmann2013 ER - TY - JOUR AU - Dancey, J. E. AU - Bedard, P. L. AU - Onetto, N. AU - Hudson, T. J. PY - 2012 DA - 2012// TI - The genetic basis for cancer treatment decisions JO - Cell VL - 148 UR - https://doi.org/10.1016/j.cell.2012.01.014 DO - 10.1016/j.cell.2012.01.014 ID - Dancey2012 ER -